933 related articles for article (PubMed ID: 18991571)
1. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
2. Luteolin, a flavonoid, as an anticancer agent: A review.
Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Orhan IE; Rizwan M; Atif M; Gondal TA; Mubarak MS
Biomed Pharmacother; 2019 Apr; 112():108612. PubMed ID: 30798142
[TBL] [Abstract][Full Text] [Related]
3. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
[TBL] [Abstract][Full Text] [Related]
4. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
5. Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.
Farooqi AA; Butt G; El-Zahaby SA; Attar R; Sabitaliyevich UY; Jovic JJ; Tang KF; Naureen H; Xu B
Pharmacol Res; 2020 Oct; 160():105188. PubMed ID: 32919041
[TBL] [Abstract][Full Text] [Related]
6. Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis.
Rocchetti MT; Bellanti F; Zadorozhna M; Fiocco D; Mangieri D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240168
[TBL] [Abstract][Full Text] [Related]
7. From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders.
Hussain MS; Gupta G; Goyal A; Thapa R; Almalki WH; Kazmi I; Alzarea SI; Fuloria S; Meenakshi DU; Jakhmola V; Pandey M; Singh SK; Dua K
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23482. PubMed ID: 37530602
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated.
Ganai SA; Sheikh FA; Baba ZA; Mir MA; Mantoo MA; Yatoo MA
Phytother Res; 2021 Jul; 35(7):3509-3532. PubMed ID: 33580629
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion.
Xu T; Li D; Jiang D
Nutrients; 2012 Dec; 4(12):2008-19. PubMed ID: 23235403
[TBL] [Abstract][Full Text] [Related]
11. Luteolin Inhibits Proliferation and Induces Apoptosis of Human Placental Choriocarcinoma Cells by Blocking the PI3K/AKT Pathway and Regulating Sterol Regulatory Element Binding Protein Activity.
Lim W; Yang C; Bazer FW; Song G
Biol Reprod; 2016 Oct; 95(4):82. PubMed ID: 27580988
[TBL] [Abstract][Full Text] [Related]
12. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells.
Jang CH; Moon N; Oh J; Kim JS
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987009
[TBL] [Abstract][Full Text] [Related]
13. Anti-carcinogenic effects of the flavonoid luteolin.
Seelinger G; Merfort I; Wölfle U; Schempp CM
Molecules; 2008 Oct; 13(10):2628-2651. PubMed ID: 18946424
[TBL] [Abstract][Full Text] [Related]
14. Molecular targets of luteolin in cancer.
Tuorkey MJ
Eur J Cancer Prev; 2016 Jan; 25(1):65-76. PubMed ID: 25714651
[TBL] [Abstract][Full Text] [Related]
15. Attenuating Smac mimetic compound 3-induced NF-kappaB activation by luteolin leads to synergistic cytotoxicity in cancer cells.
Bai L; Chen W; Wang X; Ju W; Xu S; Lin Y
J Cell Biochem; 2009 Dec; 108(5):1125-31. PubMed ID: 19739098
[TBL] [Abstract][Full Text] [Related]
16. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells.
Shi RX; Ong CN; Shen HM
Oncogene; 2004 Oct; 23(46):7712-21. PubMed ID: 15334063
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of metastasis suppression by luteolin in breast cancer.
Cook MT
Breast Cancer (Dove Med Press); 2018; 10():89-100. PubMed ID: 29928143
[TBL] [Abstract][Full Text] [Related]
18. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds.
Kim DI; Lee TK; Lim IS; Kim H; Lee YC; Kim CH
Toxicol Appl Pharmacol; 2005 Jun; 205(3):213-24. PubMed ID: 15922007
[TBL] [Abstract][Full Text] [Related]
19. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.
Prasad S; Phromnoi K; Yadav VR; Chaturvedi MM; Aggarwal BB
Planta Med; 2010 Aug; 76(11):1044-63. PubMed ID: 20635307
[TBL] [Abstract][Full Text] [Related]
20. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
